Egydose vs Residipok
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Egydose
This medical app assists healthcare professionals in calculating drug dosages for various patient types, including children, adults, and those with specific conditions. It provides detailed information on drug indications, administration, and compatibility, along with alternative suggestions and references.
- Drug dose calculation for various categories
- Dose calculation for different patient types
- Detailed drug information and administration
- Compatibility checks (pregnancy, lactation, G6PD)
- Suggested drug alternatives
- Includes multiple medical calculators
Read full descriptionHide full description
This app is directed to medical professionals. Other users who may use the app must seek doctor’s advice in addition to using this app and before making any medical decisions. *Calculate the dose of: Antibiotics and other antimicrobials All types of analgesics Anti-hypertensive drugs CNS drugs Anti-diabetic drugs GIT drugs Respiratory Tract drugs Urinary Tract and genital drugs Hormonal drugs and corticosteroids Vitamins and Minerals and more… *Calculate Dose to any Patient: Children and adults Premature infants Renal patients Hepatic patients Old age *Details: Detailed and accurate dose to every indication How to give drugs in easy way Compatibility with pregnancy and lactation Compatibility with G6PD deficiency Compatibility with Hypertension and Diabetes Mellitus Suggested alternatives if the drug is not recommended Reference with each drug *More Helpful Calculators Creatinine Clearance calculator for adults and children Child-Pugh Score for liver cirrhosis Weight converter Infusion rate calculator BSA Calculator BMI Calculator MELD Score Calculator
Residipok
Read full descriptionHide full description
Residipok is a pocket reference for licensed healthcare professionals, trainees, and medical students of accredited health-professions programs. TWO MODULES (v0.4) • MIC Lookup Choose a bacterium and an antibiotic to see the EUCAST v16.0 (2026) Clinical Breakpoint thresholds — S, I, R bands by clinical context (systemic, meningitis, urinary, high-dose). Enter an MIC value to categorise it. Special states clearly labelled when no breakpoint is published or the organism is intrinsically resistant. Built especially for pan-resistance scenarios where every threshold matters. • ESC Guideline Reference Structured Class / Level of Evidence summaries of recent ESC cardiology guidelines, covering acute coronary syndromes, heart failure, atrial fibrillation, hypertension, endocarditis, cardiomyopathies, valvular disease, pulmonary hypertension and embolism, peripheral arterial disease, dyslipidaemia, prevention, pregnancy, syncope, supraventricular tachycardia, and more. Each recommendation card links back to the original guideline on escardio.org. IMPORTANT — REFERENCE ONLY • Residipok is NOT a medical device. • It does NOT diagnose, treat, cure, or prevent disease. • It is NOT a substitute for clinical judgement or for the original published guideline / breakpoint table. • Always verify against the current EUCAST table and the latest ESC document before clinical reporting. Requires confirmation of HCP / trainee status on first launch. Sign-in by email, Apple, or Google. Sources: EUCAST Clinical Breakpoint Tables v16.0 (2026); European Society of Cardiology Clinical Practice Guidelines (2018–2024).
Screenshots
Verdict
The clearest difference is in-app purchases: Residipok at none against Egydose's 1. On price, update cadence, ads and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Egydose sells 1 one-off in-app purchase. Residipok asks for nothing beyond the download.
Egydose ships an update every 3 weeks, Residipok every 2 weeks. The most recent releases landed on September 24, 2026 and September 14, 2026 respectively.
| Parameter | Egydose | Residipok |
|---|---|---|
| Price | Free | Free |
| Rating | 4.7 (38 ratings) — better | — |
| Positive reviews | 84.6% of reviews | — |
| Number of ratings | 38 — better | — |
| Update frequency | Every 3 weeks | Every 2 weeks — better |
| Ads | Yes | Yes |
| In-app purchases | Yes | No — better |
| Monetization | Free with in-app purchases | — |
| Devices | iPhone, iPad, iPod, Mac — better | iPhone, iPad, iPod |
| Requires iOS | 15.6 | 15.1 — better |
| Further details — not scored | ||
| Size | 54 MB | 32 MB |
| Age rating | 17+ | 17+ |
| Developer | MOHAMED EL GAMMAL | Maytham Al-taan |
In-app purchases
Egydose
- Full Version$17.99
Residipok
No in-app purchases









